Data is not available at this time.
Nihon Nohyaku Co., Ltd. is a specialized agrochemical company with a diversified portfolio spanning fungicides, insecticides, herbicides, and niche chemical applications for home gardening, termite control, and animal health. Operating primarily in Japan but with an international presence, the company leverages its nearly century-old expertise to serve agricultural and pharmaceutical markets. Its subsidiary relationship with Adeka Corporation provides strategic stability, while its focus on R&D ensures competitive product differentiation in the agricultural inputs sector. The company’s dual emphasis on crop protection and animal health products positions it as a mid-tier player in a market dominated by global giants, yet it maintains regional strength through tailored solutions for Japanese farmers and niche applications like bee tick repellents. Beyond agrochemicals, Nihon Nohyaku diversifies into real estate and analytical services, though these remain ancillary to its core revenue streams.
In FY2024, Nihon Nohyaku reported revenue of ¥103 billion, with net income of ¥4.8 billion, reflecting a modest net margin of approximately 4.6%. Operating cash flow was negative at ¥-344 million, likely due to working capital adjustments or timing disparities, while capital expenditures of ¥-1.6 billion suggest ongoing investments in production or R&D. The diluted EPS of ¥60.88 underscores stable but unspectacular earnings power.
The company’s earnings are supported by its agrochemical core, though the negative operating cash flow raises questions about short-term liquidity management. With a beta of 0.15, the business exhibits low volatility, typical of defensive agricultural sectors, but its capital efficiency metrics are muted, as seen in the modest net income relative to revenue.
Nihon Nohyaku holds ¥20.6 billion in cash against ¥39.7 billion in total debt, indicating a leveraged but manageable position. The debt-to-equity ratio is not explicitly provided, but the liquidity cushion appears adequate for near-term obligations. The balance sheet reflects a traditional agrochemical firm with moderate leverage and sufficient liquidity for cyclical downturns.
Growth trends are steady rather than explosive, with the dividend payout of ¥22 per share suggesting a commitment to shareholder returns despite limited earnings growth. The company’s focus on niche markets like animal health and termite control may offer incremental growth, but broader agricultural demand cycles will likely dictate top-line performance.
At a market cap of ¥61.4 billion, the company trades at a P/E of approximately 12.9x, aligning with sector peers. The low beta implies market expectations of stability, but the valuation does not price in significant expansion, reflecting the company’s regional focus and moderate scale.
Nihon Nohyaku’s strengths lie in its long-standing market presence, diversified agrochemical portfolio, and Adeka Corporation’s backing. However, its outlook is tempered by competitive pressures and reliance on Japan’s agricultural sector. Strategic investments in R&D and international expansion could enhance growth, but execution risks remain.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |